Package 64980-659-10

{"route": ["ORAL"], "spl_id": "356b3e79-d47b-467a-af62-2adca35f1a2f", "openfda": {"unii": ["B53E3NMY5C"], "rxcui": ["313412", "313413"], "spl_set_id": ["433ac98f-ac22-44ad-a8b4-5db5560b9d0f"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (64980-659-03)", "package_ndc": "64980-659-03", "marketing_start_date": "20241215"}, {"sample": false, "description": "1000 TABLET in 1 BOTTLE (64980-659-10)", "package_ndc": "64980-659-10", "marketing_start_date": "20241215"}, {"sample": false, "description": "150 TABLET in 1 BOTTLE (64980-659-15)", "package_ndc": "64980-659-15", "marketing_start_date": "20241215"}], "brand_name": "tizanidine", "product_id": "64980-659_356b3e79-d47b-467a-af62-2adca35f1a2f", "dosage_form": "TABLET", "pharm_class": ["Adrenergic alpha2-Agonists [MoA]", "Central alpha-2 Adrenergic Agonist [EPC]"], "product_ndc": "64980-659", "generic_name": "tizanidine", "labeler_name": "Rising Pharma Holdings, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "tizanidine", "active_ingredients": [{"name": "TIZANIDINE HYDROCHLORIDE", "strength": "4 mg/1"}], "application_number": "ANDA218920", "marketing_category": "ANDA", "marketing_start_date": "20241215", "listing_expiration_date": "20261231"}